Published in Naunyn Schmiedebergs Arch Pharmacol on February 01, 1983
Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons. Psychopharmacology (Berl) (2009) 0.89
Chronic intragastric administration of gamma-butyrolactone produces physical dependence in baboons. Psychopharmacology (Berl) (2006) 0.88
Gammahydroxybutyrate (GHB) receptor ligand effects on evoked synaptic field potentials in CA1 of the rat hippocampal slice. J Neural Transm (Vienna) (1997) 0.77
Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci (2003) 3.38
Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci (2000) 2.00
Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci (1986) 1.79
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci (1994) 1.63
The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis (2006) 1.56
Delayed absorption of phenylbutazone caused by desmethylimipramine in humans. Eur J Pharmacol (1970) 1.47
Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci U S A (1987) 1.37
A quantitative study of the anticholinergic action of several tricyclic antidepressants on the rat isolated fundal strip. Br J Pharmacol (1972) 1.36
Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett (1984) 1.29
Studies on the in vitro interaction of electrical stimulation and Ca++ movement in sarcoplasmic reticulum. J Gen Physiol (1966) 1.28
Acute induction of epileptiform discharges by pilocarpine in the in vitro isolated guinea-pig brain requires enhancement of blood-brain barrier permeability. Neuroscience (2007) 1.25
Desipramine and amphetamine metabolism. J Pharm Pharmacol (1967) 1.19
Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience (2005) 1.14
Altered expression of GABA(A) and GABA(B) receptor subunit mRNAs in the hippocampus after kindling and electrically induced status epilepticus. Neuroscience (2005) 1.12
Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy. Neurobiol Dis (2013) 1.10
Characterization of the muscarinic receptor subtypes in the rat urinary bladder. Eur J Pharmacol (1988) 1.10
Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.08
Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle. Mol Pharmacol (1988) 1.08
Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant. Life Sci (1974) 1.06
Myocardial ischaemia in neonates with perinatal asphyxia. Electrocardiographic, echocardiographic and enzymatic correlations. Eur J Pediatr (1999) 1.06
Cholinacetylase in innervated and denervated sympathetic ganglia and ganglion cells of the cat. Acta Physiol Scand (1967) 1.06
Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1. J Intern Med (2011) 1.06
M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci U S A (1991) 1.05
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03
A micromethod for the determination of choline acetylase in individual cells. Acta Physiol Scand (1967) 1.02
Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116. Eur J Pharmacol (1987) 1.01
Ground-state fidelity and bipartite entanglement in the Bose-Hubbard model. Phys Rev Lett (2007) 1.01
N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci U S A (1989) 1.00
Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience (1995) 1.00
Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A (1993) 1.00
Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.99
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98
Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci (1987) 0.96
5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport (1994) 0.96
Dynamic induction of the long pentraxin PTX3 in the CNS after limbic seizures: evidence for a protective role in seizure-induced neurodegeneration. Neuroscience (2001) 0.95
Role of the hippocampus in the sex-dependent regulation of eating behavior: studies with kainic acid. Physiol Behav (1986) 0.94
Galanin receptor and its ligands in the rat hippocampus. Eur J Biochem (1989) 0.92
Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice. Eur J Neurosci (2002) 0.92
Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility. Neuroscience (2009) 0.91
Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus. Gene Ther (2010) 0.91
Impulse flow dependency of galanin release in vivo in the rat ventral hippocampus. Proc Natl Acad Sci U S A (1994) 0.91
Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol Aging (1988) 0.90
Distinct changes in peptide YY binding to, and mRNA levels of, Y1 and Y2 receptors in the rat hippocampus associated with kindling epileptogenesis. J Neurochem (1998) 0.89
Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Res Brain Res Rev (1996) 0.89
Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol Sci (1988) 0.88
Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors. Eur J Neurosci (1998) 0.88
D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J Neurochem (1990) 0.88
Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience (1995) 0.87
Chronic morphine induces long-lasting changes in acetylcholine release in rat nucleus accumbens core and shell: an in vivo microdialysis study. Psychopharmacology (Berl) (1999) 0.87
Characterization of muscarinic receptor subtypes in human tissues. Life Sci (1988) 0.87
Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. J Neurochem (1994) 0.87
Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Brain Res Mol Brain Res (1996) 0.86
In vivo brain dialysis of amino acids and simultaneous EEG measurements following intrahippocampal quinolinic acid injection: evidence for a dissociation between neurochemical changes and seizures. J Neurochem (1985) 0.86
Activity of centrally administered galanin fragments on stimulation of feeding behavior and on galanin receptor binding in the rat hypothalamus. J Neurosci (1990) 0.86
Storage and release of acetylcholine in the isolated superior cervical ganglion of the rat. Brain Res (1978) 0.86
Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+ channels. J Neurochem (1991) 0.86
Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology (1994) 0.85
Hematologic and biochemical profiles of selectively bred WHHL rabbits. Lab Anim Sci (1993) 0.84
Extracellular glutamate levels in the hypothalamus and hippocampus of rats after acute or chronic oral intake of monosodium glutamate. Neurosci Lett (1995) 0.84
Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J Neurochem (1987) 0.83
Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur J Neurosci (1993) 0.83
Molecular aspects of cloricromene (AD6) distribution in human platelets and its pharmacological effects. Thromb Res (1989) 0.83
Acetylcholine, choline and choline acetyltransferase activity in the developing brain of normal and hypothyroid rats. J Neurochem (1972) 0.83
[Left ventricular false tendon: the most frequent cause of "innocent" murmur in childhood?]. G Ital Cardiol (1992) 0.82
Novel and highly potent 5-HT3 receptor agonists based on a pyrroloquinoxaline structure. J Med Chem (1997) 0.82
Neuroprotective effect of somatostatin on nonapoptotic NMDA-induced neuronal death: role of cyclic GMP. J Neurochem (1997) 0.82
Rare and atypical forms of Tako-Tsubo cardiomyopathy diagnosed by contrast-echocardiography during subarachnoid haemorrhage: confirming the appropriateness of the new Tako-Tsubo classification. Int J Cardiol (2011) 0.82
Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice. Eur J Neurosci (1999) 0.82
Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience (1991) 0.82
Decreased Ca2+ uptake by sarcoplasmic reticulum after coronary artery occlusion for 60 and 90 minutes. Circ Res (1967) 0.81
Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures. Neuroscience (1996) 0.81
Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism. Neuropharmacology (1997) 0.81
Effect of chemical sympathectomy on the content of acetylcholine, choline and choline acetyltransferase activity in the cat spleen and iris. J Physiol (1972) 0.81
Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.81
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology. Life Sci (1993) 0.81
Peritonectomy and hyperthermic antiblastic perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Oncol (2000) 0.81
Cell metabolism in patients undergoing major valvular heart surgery: relationship with intra and postoperative hemodynamics, oxygen transport, and oxygen utilization patterns. Crit Care Med (1989) 0.80
Genetic toxicity of a mixture of fifteen pesticides commonly found in the Italian diet. Cell Biol Toxicol (1994) 0.80
Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedebergs Arch Pharmacol (1994) 0.80
Pharmacokinetics of mifentidine after single and multiple oral administration to healthy volunteers. Br J Clin Pharmacol (1988) 0.80
Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus. Eur J Pharmacol (1988) 0.80
Effect of desipramine on intestinal absorption of phenylbutazone and other drugs. Eur J Pharmacol (1969) 0.80
Increased preproneuropeptide Y mRNA in the rat hippocampus during the development of hippocampal kindling: comparison with the expression of preprosomatostatin mRNA. Neurosci Lett (1991) 0.80
Anti-excitotoxic actions of taurine in the rat hippocampus studied in vivo and in vitro. Adv Exp Med Biol (1986) 0.80
The orphan receptor cDNA RDC4 encodes a 5-HT1D serotonin receptor. Biochem Biophys Res Commun (1991) 0.79
Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics. Adv Biochem Psychopharmacol (1980) 0.79
Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms, and relationships with skeletal muscle phosphorus content. Chest (1990) 0.79
Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res (1994) 0.79
Endogenous serotonin facilitates in vivo acetylcholine release in rat frontal cortex through 5-HT 1B receptors. J Pharmacol Exp Ther (1996) 0.79
Stimulation of 5-HT1A receptors in the dorsal hippocampus and inhibition of limbic seizures induced by kainic acid in rats. Br J Pharmacol (1996) 0.79
N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo. Brain Res (1993) 0.79
Neurochemical effects of buspirone, a novel psychotropic drug, on the central cholinergic system. J Pharm Pharmacol (1982) 0.79